GSK plc (GSK) — Analyst outlook / Analyst consensus target is. Based on 29 analyst ratings, the consensus is bullish — 9 Buy, 16 Hold, 4 Sell.
The consensus price target is $53.00, representing a downside of 10.4% from the current price $59.18.
Analysts estimate Earnings Per Share (EPS) of $3.85 and revenue of $38.73B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.26 vs est $3.85 (missed -67.3%). 2025: actual $2.76 vs est $4.54 (missed -39.2%). Analyst accuracy: 0%.
GSK Stock — 12-Month Price Forecast
$53.00
▼ -10.44% Downside
Average Price Target
Based on 29 Wall Street analysts offering 12-month price targets for GSK plc, the price target is $53.00.
The average price target represents a -10.44% change from the last price of $59.18.
GSK Analyst Ratings
Hold
Based on 29 analysts giving stock ratings to GSK plc in the past 3 months
EPS Estimates — GSK
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1.26
vs Est $3.85
▼ 205.9% off
2025
Actual $2.76
vs Est $4.54
▼ 64.4% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — GSK
70%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $31.376B
vs Est $38.732B
▼ 23.4% off
2025
Actual $31.951B
vs Est $43.638B
▼ 36.6% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
